vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and INNOVATIVE INDUSTRIAL PROPERTIES INC (IIPR). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $66.7M, roughly 1.8× INNOVATIVE INDUSTRIAL PROPERTIES INC). INNOVATIVE INDUSTRIAL PROPERTIES INC runs the higher net margin — 47.8% vs 4.2%, a 43.6% gap on every dollar of revenue. On growth, Core Laboratories Inc. posted the faster year-over-year revenue change (-1.4% vs -13.1%). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -6.0%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Oxford Properties is a Canadian multinational corporation, with operations in real estate investment, development and property management. Its portfolio includes office, retail, industrial, multi-residential, life sciences and hotel assets. Established privately in 1960 and later wholly owned by the Ontario Municipal Employees Retirement System (OMERS) since 2003, the company is headquartered in Toronto with regional head offices in New York City, London, Australia, Singapore and Luxembourg. ...

CLB vs IIPR — Head-to-Head

Bigger by revenue
CLB
CLB
1.8× larger
CLB
$121.8M
$66.7M
IIPR
Growing faster (revenue YoY)
CLB
CLB
+11.7% gap
CLB
-1.4%
-13.1%
IIPR
Higher net margin
IIPR
IIPR
43.6% more per $
IIPR
47.8%
4.2%
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-6.0%
IIPR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
IIPR
IIPR
Revenue
$121.8M
$66.7M
Net Profit
$5.1M
$31.8M
Gross Margin
Operating Margin
1.5%
47.8%
Net Margin
4.2%
47.8%
Revenue YoY
-1.4%
-13.1%
Net Profit YoY
-20.4%
EPS (diluted)
$0.11
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
IIPR
IIPR
Q1 26
$121.8M
Q4 25
$138.3M
$66.7M
Q3 25
$134.5M
$64.7M
Q2 25
$130.2M
$62.9M
Q1 25
$123.6M
$71.7M
Q4 24
$129.2M
$76.7M
Q3 24
$134.4M
$76.5M
Q2 24
$130.6M
$79.8M
Net Profit
CLB
CLB
IIPR
IIPR
Q1 26
$5.1M
Q4 25
$4.9M
$31.8M
Q3 25
$14.2M
$29.3M
Q2 25
$10.6M
$26.0M
Q1 25
$-154.0K
$31.1M
Q4 24
$7.4M
$40.0M
Q3 24
$11.7M
$40.2M
Q2 24
$9.0M
$42.0M
Gross Margin
CLB
CLB
IIPR
IIPR
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
IIPR
IIPR
Q1 26
1.5%
Q4 25
11.5%
47.8%
Q3 25
15.6%
45.5%
Q2 25
11.7%
45.9%
Q1 25
3.6%
47.4%
Q4 24
11.0%
54.7%
Q3 24
14.7%
54.8%
Q2 24
12.3%
53.1%
Net Margin
CLB
CLB
IIPR
IIPR
Q1 26
4.2%
Q4 25
3.6%
47.8%
Q3 25
10.6%
45.3%
Q2 25
8.2%
41.4%
Q1 25
-0.1%
43.3%
Q4 24
5.7%
52.2%
Q3 24
8.7%
52.6%
Q2 24
6.9%
52.6%
EPS (diluted)
CLB
CLB
IIPR
IIPR
Q1 26
$0.11
Q4 25
$0.11
$1.07
Q3 25
$0.30
$0.97
Q2 25
$0.22
$0.86
Q1 25
$0.00
$1.03
Q4 24
$0.15
$1.35
Q3 24
$0.25
$1.37
Q2 24
$0.19
$1.44

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
IIPR
IIPR
Cash + ST InvestmentsLiquidity on hand
$22.8M
$47.6M
Total DebtLower is stronger
$393.7M
Stockholders' EquityBook value
$275.1M
$1.8B
Total Assets
$587.7M
$2.4B
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
IIPR
IIPR
Q1 26
$22.8M
Q4 25
$22.7M
$47.6M
Q3 25
$25.6M
$41.9M
Q2 25
$31.2M
$104.9M
Q1 25
$22.1M
$133.3M
Q4 24
$19.2M
$151.2M
Q3 24
$21.5M
$172.4M
Q2 24
$17.7M
$160.9M
Total Debt
CLB
CLB
IIPR
IIPR
Q1 26
Q4 25
$110.3M
$393.7M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
IIPR
IIPR
Q1 26
$275.1M
Q4 25
$266.0M
$1.8B
Q3 25
$271.3M
$1.9B
Q2 25
$261.3M
$1.9B
Q1 25
$253.4M
$1.9B
Q4 24
$246.6M
$1.9B
Q3 24
$250.7M
$1.9B
Q2 24
$240.3M
$1.9B
Total Assets
CLB
CLB
IIPR
IIPR
Q1 26
$587.7M
Q4 25
$584.0M
$2.4B
Q3 25
$591.4M
$2.3B
Q2 25
$602.1M
$2.3B
Q1 25
$591.5M
$2.4B
Q4 24
$585.1M
$2.4B
Q3 24
$600.5M
$2.4B
Q2 24
$597.8M
$2.4B
Debt / Equity
CLB
CLB
IIPR
IIPR
Q1 26
Q4 25
0.41×
0.21×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
IIPR
IIPR
Operating Cash FlowLast quarter
$4.0M
$198.2M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
6.22×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
IIPR
IIPR
Q1 26
$4.0M
Q4 25
$7.9M
$198.2M
Q3 25
$8.5M
$45.6M
Q2 25
$13.9M
$48.4M
Q1 25
$6.7M
$54.2M
Q4 24
$20.6M
$258.4M
Q3 24
$13.1M
$64.9M
Q2 24
$17.1M
$64.2M
Free Cash Flow
CLB
CLB
IIPR
IIPR
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
IIPR
IIPR
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
IIPR
IIPR
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
IIPR
IIPR
Q1 26
0.77×
Q4 25
1.61×
6.22×
Q3 25
0.60×
1.56×
Q2 25
1.31×
1.86×
Q1 25
1.75×
Q4 24
2.78×
6.46×
Q3 24
1.12×
1.61×
Q2 24
1.90×
1.53×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons